Ricolinostat (ACY-1215), the first selective histone deacetylase 6 inhibitor, is active and well tolderated in combination with lenalidomide or bortezomib in patients with refractory myeloma

Authors
Category Primary study
JournalHaematologica
Year 2014
This article has no abstract
Epistemonikos ID: b57319739aee1a1327f34b40a1d9cd5a58383f35
First added on: Feb 06, 2025